Recently, RASGRP4 was reported to be highly expressed but not mutated in a limited number of DLBCL (4–7 cases) and other B cell malignancies (5 each of follicular lymphoma and Burkitt lymphoma), and when compared to normal and activated B cells21. This evidence concerns the gene RASGRP4 and follicular lymphoma.